Oscar Health (OSCR) Scheduled to Post Quarterly Earnings on Tuesday

Oscar Health (NYSE:OSCR) is scheduled to post its quarterly earnings results before the market opens on Tuesday, May 7th. Analysts expect Oscar Health to post earnings of $0.28 per share for the quarter. Oscar Health has set its FY 2024 guidance at EPS.Parties that wish to register for the company’s conference call can do so using this link.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, beating the consensus estimate of ($0.74) by $0.08. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The business had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.43 billion. During the same period last year, the business earned ($1.05) earnings per share. The firm’s revenue was up 43.9% on a year-over-year basis. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Oscar Health Stock Performance

NYSE OSCR opened at $18.02 on Friday. The firm has a market capitalization of $4.14 billion, a P/E ratio of -15.02 and a beta of 1.66. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.37. The firm’s fifty day moving average price is $15.30 and its two-hundred day moving average price is $11.67. Oscar Health has a 1 year low of $4.72 and a 1 year high of $18.69.

Analyst Upgrades and Downgrades

OSCR has been the topic of a number of research analyst reports. Wells Fargo & Company upped their target price on shares of Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a report on Thursday, February 15th. TheStreet upgraded Oscar Health from a “d” rating to a “c-” rating in a research note on Wednesday, February 21st. Raymond James assumed coverage on Oscar Health in a research note on Friday, March 22nd. They set an “outperform” rating and a $20.00 target price for the company. Finally, The Goldman Sachs Group boosted their target price on Oscar Health from $8.00 to $16.00 and gave the stock a “neutral” rating in a report on Friday, February 9th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $13.50.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.